Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00832832 · ClinicalTrials.gov registry record · NA
Eyelid Closure in Glaucoma Therapy
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00832832: Completed NA study, sponsored by Johns Hopkins University.
NCT00832832 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00832832, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This research is being done to determine if closing your eyelids after you take your glaucoma drops makes them more effective in lowering your eye pressure, and to determine if closing your eyelids for 5 minutes is better than closing them for one minute
Interventions
- OTHER Eyelid closure
- OTHER No intervention will be assigned
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00832832
The ClinicalTrials.gov registry entry for NCT00832832 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Eyelid closure is the first listed.
NCT00832832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00832832 about?
NCT00832832 is a clinical study titled "Eyelid Closure in Glaucoma Therapy". This research is being done to determine if closing your eyelids after you take your glaucoma drops makes them more effective in lowering your eye pressure, and to determine if closing your eyelids for 5 minutes is better than closing them for one minute
What is the current status of trial NCT00832832?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2009-01. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00832832?
The interventions under investigation include: Eyelid closure (OTHER), No intervention will be assigned (OTHER).
Who is sponsoring clinical trial NCT00832832?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.